The results, in addition to shedding light on the antiproliferative/pro-apoptotic mechanism of CA by clarifying whether TG2 is involved, should have possible implications in the treatment of CML. The gene discussed is TGM2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.